Bulletin references July 2021
A full list of references for the July Bulletin is available here.
You can download a copy of the July 2021 Bulletin from our Bulletin pages.
Perinatal mortality – are we learning?
- Kirkup B. The Report of the Morecambe Bay Investigation. Accessed April 2021. Available at: www.gov.uk/government/publications/morecambe-bay-investigation-report
- Department of Health and Social Care. Safer Maternity Care – Next Steps Towards the National Maternity Ambition. Accessed April 2021. Available at: www.gov.uk/government/publications/safer-maternity-care
- Cumberlege JF. Better Births – Improving Outcomes of Maternity Services in England. Accessed April 2021. Available at: www.england.nhs.uk/publication/better-births-improving-outcomes-of-maternity-services-in-england-a-five-year-forward-view-for-maternity-care/
- NHS England. Saving Babies Lives. Accessed April 2021. Available at: www.england.nhs.uk/?s=saving+babies+lives
- Royal College of Obstetricians and Gynaecologists. Each Baby Counts 2019 Progress Report. Accessed April 2021. Available at: www.rcog.org.uk/en/guidelines-research-services/audit-quality-improvement/each-baby-counts/reports-updates/
- Department of Health and Social Care. The National Maternity Safety Strategy - Progress and Next Steps. Accessed April 2021. Available at: www.gov.uk/government/publications/safer-maternity-care
- Department of Health and Social Care. Evidence Submission for the Health and Social Care Committee Inquiry – Safety of Maternity Services in England. Accessed April 2021. Available at: https://committees.parliament.uk/writtenevidence/11114/html/
- Ockenden D. Maternity Services at the Shrewsbury and Telford Hospital NHS Trust. Accessed April 2021. Available at: www.gov.uk/government/publications/ockenden-review-of-maternity-services-at-shrewsbury-and-telford-hospital-nhs-trust
- IIEKMS. Independent Investigation into East Kent Maternity Services. Accessed April 2021. Available at: https://iiekms.org.uk/
- Spiegelhalter DJ. Funnel plots for comparing institutional performance. Statist Med 2005;24:1185–1202.
- Flenady V, Wojcieszek AM, Middleton P, Ellwood D, Erwich JJ, Coory M et al. Stillbirths: Recall to action in high-income countries. Lancet 2016;387:691–702.
The evolution of paediatric laboratory medicine
- Chemical Pathology: Clinical Tests and Paediatric . Clayton BE, Jenkins P, Round JM, 1980.Blackwell Scientific PublicationsNew Jersey, USA: .Reference Ranges
- Meites S. Pediatric Clinical Chemistry: Reference (Normal) Values. Washington DC, AACC Press, 1989.
- Coakley J. 40 years of paediatric chemical pathology – a personal view. Pathol 2015;47:14.
- Coffin CM, Hamilton MS, Pysher TJ, Bach P, Ashwood E, Schweiger J et al. Paediatric laboratory medicine: current challenges and future opportunities. Am J Clinical Pathol 2002;117:683–690.
- Kohse KP. A worldwide paediatric laboratory medicine network: the International Federation of Clinical Chemistry Task Force on Paediatric Laboratory Medicine (IFCC TF-PLM). J Clin Pathol 2009;62:193–194.
- Grey VL, Loh TP, Metz M, Lang T, Hersberger M. Paediatric laboratory medicine – some reflections on the sub-specialty. Clin Biochem 2017;50:648–650.
- South African Association for Clinical Biochemistry and Laboratory Medicine. SAACB News. 2018. Available at: http://www.saclinpath.co.za/newsletters/SAACB_Feb_2018_newsletter.pdf
- Jones PM, Dietzen D, Haymond S, Bennett M. Paediatric Laboratory Medicine (1st edition). New York, USA: McGraw-Hill Education, 2017.
- Bowron A, Merrett N. The metabolic biochemistry network: an update and review of resources. In: ACB News. London, UK: Association for Clinical Biochemistry and Laboratory Medicine, 2018.
Major obstetric haemorrhage – achievements and ongoing challenges
- Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J et al. Global causes of maternal death: A WHO systematic analysis. Lancet Glob Heal 2014;2:323–333.
- Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife D, Garrod D et al. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008. An Int J Obstet Gynaecol 2011;118:1–203.
- Lennox C, Marr L. Scottish Confidential Audit of Severe Maternal Morbidity: Reducing Avoidable Harm. 10th Annual Report. Accessed 12 March 2021. Available here.
- Mavrides E, Allard S, Chandraharan E, Collins P, Green L, Hunt BJ et al. Prevention and management of postpartum haemorrhage. An Int J Obstet Gynaecol 2016;124:106–149.
- Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle MH, Ford JB et al. Trends in postpartum hemorrhage in high resource countries: A review and recommendations from the international postpartum hemorrhage collaborative group. BMC Pregnancy Childbirth 2009;9:55
- Hunt BJ, Allard S, Keeling D, Norfolk D, Stanworth SJ, Pendry K et al. A practical guideline for the haematological management of major haemorrhage. Br J Haematol 2015;170:788–803.
- Whiting P, Al M, Westwood M, Corro Ramos I, Ryder S, Armstrong N et al. Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: A systematic review and cost-effectiveness analysis. Health Technol Assess 2015;19:1–228.
- Amgalan A, Allen T, Othman M, Ahmadzia HK. Systematic review of viscoelastic testing (TEG/ROTEM) in obstetrics and recommendations from the women’s SSC of the ISTH. J Thromb Haemost 2020;18:1813–1838.
- WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 2017;389:2105–2116.
- Charbit B, Mandlebrot L, Samain E, Baron G, Haddaoui B, Keita H et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007;5:266–273.
- Zaidi A, Kohli R, Daru J, Estcourt L, Khan KS, Thangaratinam S et al. Early use of fibrinogen replacement therapy in postpartum hemorrhage – a systematic review. Transfus Med Rev 2020;34:101–107.
- Ducloy-Bouthors AS, Mercier FJ, Grouin JM, Bayoumeu F, Corouge J, Le Gouez A et al. Early and systematic administration of fibrinogen concentrate in postpartum haemorrhage following vaginal delivery: the FIDEL randomised controlled trial. BJOG 2021;doi:10.1111/1471-0528.16699 (Epub ahead of print).
- Green L, Daru J, Dodds J, Gonzalez Carreras FJ, Lanz D, Zamora J et al. Effect of early cryoprecipitate transfusion versus standard care in women who develop severe postpartum haemorrhage (ACROBAT) in the UK: a protocol for a pilot cluster randomised trial. BMJ Open 2020;10:e036416.
- Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E et al. Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. J Thromb Haemost 2015;13:520–529.
- Khan KS, Moore P, Wilson M, Hooper R, Allard S, Wrench I et al. A randomised controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: The salvo (cell salvage in obstetrics) trial. Health Technol Assess 2018;22:1–88.
Healthcare Safety Investigation Branch
- Healthcare Safety Investigation Branch. Maternal Death: Learning from Maternal Death Investigations During the First Wave of the COVID-19 Pandemic. Accessed 23 April 2021. Available at: www.hsib.org.uk/investigations-cases/maternal-death-national-learning-report/
- Department of Health and Social Care. Coronavirus: Stay at Home, Protect the NHS, Save Lives. Accessed 12 February 2021. Available at: www.gov.uk/government/publications/coronavirus-covid-19-information-leaflet/coronavirus-stay-at-home-protect-the-nhs-save-lives-web-version
- Healthcare Safety Investigation Branch. COVID-19 Transmission in Hospitals: Management of the Risk – A Prospective Safety Investigation. Accessed 12 February 2021. Available at: www.hsib.org.uk/investigations-cases/covid-19-transmission-hospitals/
- Monari F, Pedrielli G, Vergani P, Pozzi E, Mecacci F, Serenaet C et al. Adverse perinatal outcome in subsequent pregnancy after stillbirth by placental vascular disorders. PLoS One 2016;11:e0155761.
- Heazell AE, Martindale EA. Can post-mortem examination of the placenta help determine the cause of stillbirth? J Obstet Gynaecol 2009;29:225–228.
- Vik T, Redline R, Nelson KB, Bjellmo S, Vogt C, Ng P et al. The placenta in neonatal encephalopathy: A case-control study. J Pediatr 2018;202:77–85.
- Cox P, Evans C. Tissue Pathway for Histopathological Examination of the Placenta. London, UK: The Royal College of Pathologists, 2019. Available at: www.rcpath.org/G108-Tissue-pathway-for-histopathological-examination-of-the-placenta
Successes and challenges in newborn screening for metabolic disorders
- European Commission. EU Research on Rare Diseases. Available at: https://ec.europa.eu/info/research-and-innovation/research-area/health-research-and-innovation/rare-diseases_en
- Office for National Statistics. Child Mortality (death cohort) Tables in England and Wales for 2019. Available here.
- UK National Screening Committee. Criteria for Appraising the Viability, effectiveness and appropriateness of a Screening Programme. Available at: www.gov.uk/government/publications/evidence-review-criteria-national-screening-programmes/criteria-for-appraising-the-viability-effectiveness-and-appropriateness-of-a-screening-programme
- Bessey A, Chilcott J, Pandor A, Paisley S. The cost-effectiveness of expanding the UK newborn bloodspot screening programme to include five additional inborn errors of metabolism. Int J Neonatal Screen 2020;6:93.
- American College of Medical Genetics and Genomics. ACMG ACT Sheets and Algorithms. www.acmg.net/ACMG/Medical-Genetics-Practice-Resources/ACT_Sheets_and_Algorithms.aspx
- Public Health England. Newborn Bloodspot Screening Programme in the UK. Available here.
Rh-D haemolytic disease of the fetus and newborn – the role of SHOT in improving care
- NICE. Routine Antenatal Anti-D Prophylaxis for Women Who Are Rhesus D Negative. Accessed May 2021. Available at: www.nice.org.uk/guidance/ta156/chapter/2-Clinical-need-and-practice
- Qureshi H, Massey E, Kirwan D, Davies T, Robson S, White J et al. BCSH guideline for the use of anti‐D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med 2014;24:8–20.
- NICE. High-throughput Non-invasive Prenatal Testing for Fetal RHD Genotype. Accessed May 2021. Available at: www.nice.org.uk/guidance/dg25/chapter/3-the-diagnostic-tests
- Serious Hazards of Transfusion. Annual SHOT Report 2020. Accessed May 2021. Available at: https://www.shotuk.org/shot-reports/
- Serious Hazards of Transfusion. Anti-D Aide Memoire. Available at: www.shotuk.org/wp-content/uploads/myimages/Anti-D-Aide-Memoire-July-2020.pdf
- Serious Hazards of Transfusion. Bite No. 2 Anti-D Ig Administration. Available at: www.shotuk.org/resources/current-resources/shot-bites/
- NHS Blood and Transplant. Molecular Diagnostics – Optimising Antenatal Care. Available at: https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/16291/inf1481-ibgrl-brochure.pdf
Anaemia in pregnancy and the postpartum period
- World Health Organization. The Global Prevalence of Anaemia in 2011. Geneva, Switzerland: WHO, 2015.
- Pavord S, Myers B, Robinson S, Allard S, Strong J, Oppenheimer C. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol 2021;156:588–600.
- Pavord S, Daru J, Prasannan N, Robinson S, Stanworth S, Girling J. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol 2020;188:819–830.
- Global Nutrition Report. 2020 Global Nutrition Report. Available at: https://globalnutritionreport.org/reports/2020-global-nutrition-report/
- NHS Blood and Transplant. 2018/19 Audit of the Management of Maternal Anaemia and Iron Deficiency in the UK and Republic of Ireland. Available at: https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/19996/2018-maternal-anaemia-audit-summary.pdf
- Figueiredo ACMG, Gomes-Filho IS, Batista JET, Orrico GS, Porto ECL, Pimenta RMC et al. Maternal anemia and birth weight: A prospective cohort study. PLoS One 2019;14:0212817.
- Rahmati S, Azami M, Badfar G, Parizad N, Sayehmiri K. The relationship between maternal anemia during pregnancy with preterm birth: a systematic review and meta-analysis. J Matern Neonatal Med 2020;33:2679–2689.
- Azami M, Badfar G, Khalighi Z, Qasemi P, Shohami M, Soleymani A et al. The association between anemia and postpartum depression: A systematic review and meta-analysis. Caspian J Intern Med 2019;10:115–124.
- Sheikh M, Hantoushzadeh S, Shariat M, Farahani Z, Ebrahiminasab O. The efficacy of early iron supplementation on postpartum depression, a randomized double-blind placebo-controlled trial. Eur J Nutr 2017;56:901–908.
Post-partum haemorrhage in Africa: achievements and ongoing challenges
- WHO, UNICEF. Revised 1990 estimates of maternal mortality: a new approach by WHO and UNICEF. Geneva: World Health Organization, 1996. Available here.
- WHO, UNICEF, UNFPA. Maternal mortality in 1995: estimates developed by WHO, UNICEF, UNFPA. Geneva: World Health Organization, 2001. Available at: https://apps.who.int/iris/handle/10665/66837
- Rattray RS. Religion and Art in Ashanti. Oxford, UK: Oxford University Press, Chapter VI, pp 86−115, 1927.
- Harrison KA. Maternal Mortality in Nigeria: The Real Issues. Afr J Reprod Health 1997;1:7−13.
- United Nations. World Population Prospects, The 2006 Revision. Volume I: Comprehensive Tables. NY, USA: Department of Economic and Social Affairs, 2007. Available here.
- United Nations. World Population Prospects: The 2000 Revision: Highlights. NY, USA: Department of Economic and Social Affairs, 2001.
- WHO, UNICEF, UNFPA, World Bank Group and United Nations Population Division. Trends in maternal mortality: 1990 to 2015. Published 2015. Available at: http://apps.who.int/iris/bitstream/handle/10665/194254/9789241565141_eng.pdf?sequence=1
- Loudon I. Death in Childbirth: An International Study of Maternal Care and Maternal Mortality, 1800–1950. Oxford, UK: Clarendon Press, 1992.
- United Nations. The Millennium Development Goals Report. Published 2015. Available at: www.un.org/millenniumgoals/2015_MDG_Report/pdf/MDG%202015%20rev%20(July%201).pdf
- Ahmed S, Li Q, Liu L, Tsui AO. Maternal deaths averted by contraceptive use: an analysis of 172 countries. The Lancet 2012;380:111−125.
- Manasyan A, Saleem S, Koso-Thomas M, Althabe F, Pasha O, Chomba E et al; for the EmONC Trial Group. Assessment of Obstetric and Neonatal Health Services in Developing Country Health Facilities. Am J Perinatol 2013;30:787–794.
- Wong KLM, Benova L, Campbell OMR. A look back on how far to walk: Systematic review and meta-analysis of physical access to skilled care for childbirth in Sub-Saharan Africa. PLoS One 2017;12:e0184432.
- Tessema ZT, Tesema GA. Pooled prevalence and determinants of skilled birth attendant delivery in East African countries: a multilevel analysis of Demographic and Health Surveys. Ital J Pediatr 2020;46:177.
- Fagbamigbe AF, Hurricane-Ike EO , Yusuf OB, Idemudia ES. Trends and drivers of skilled birth attendant use in Nigeria (1990−2013): policy implications for child and maternal health. Int J Womens Health 2017;9:843−853.
- Medical and Dental Council of Ghana. Available at: www.mdcghana.org
- Bearak J, Popinchalk A, Ganatra B, Moller A-B, Tunçalp O, Beavin C et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990–2019. Lancet Glob Health 2020;8:e1152−e1161.
- Ahmed S, Choi Y, Rimon JG, Alzouma S, Gichangi P, Guiella G et al. Trends in contraceptive prevalence rates in sub-Saharan Africa since the 2012 London Summit on Family Planning: results from repeated cross-sectional surveys. Lancet Glob Health 2019;7:e904−e911.
- Ntambue AM, Malonga FK, Cowgill KD, Dramaix-Wilmet MP. Emergency obstetric and neonatal care availability, use, and quality: a cross-sectional study in the city of Lubumbashi, Democratic Republic of the Congo, 2011. BMC Pregnancy Childbirth 2017;17:40.
- Mirkuzie AH, Sisay MM, Reta AT, Bedane MM. Current evidence on basic emergency obstetric and newborn care services in Addis Ababa, Ethiopia; a cross sectional study. BMC Pregnancy Childbirth 2014;14:354.
- Mullany LC, Newton S, Afari-Asiedu S, Adiibokah E, Agyemang CT, Cofie P et al. Cumulative effects of heat exposure and storage conditions of Oxytocin-in-Uniject in rural Ghana: implications for scale up. Glob Health Sci Pract 2014;2:285–294.
Is our freedom from brucellosis going to the dogs?
- Wyatt, HV. Lessons from the history of brucellosis. Rev Sci Tech 2013;32:17–25.
- Young DA. Florence Nightingale’s fever. Brit Med J 1995;311:1697–1700.
- Eyre JW. Recent work on Mediterranean Fever. Int J Med 1908;1:209–222.
- Carmichael LE, Kenney RM. Canine abortion caused by Brucella canis. J Am Vet Med Assoc 1968;152:605–616.
- World Health Organisation. Brucellosis. Accessed April 2021. Available at: www.who.int/news-room/fact-sheets/detail/brucellosis
- Hensel ME, Negron M, Arenas-Gamboa AM. Brucellosis in dogs and public health risk. Emerg Infect Dis 2018;24:1401–1406.
- Cosford KL. Brucella canis: An update on research and clinical management. Can Vet J 2018;59:74–81.
- Wurtz N, Papa A, Hukic M, Caro AD, Leparc-Goffart I, Leroy E et al. Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories. Eur J Clin Microbiol Infect Dis 2016;35:1247–1258.
- Weinstein RA, Singh K. Laboratory-acquired infections. Clin Infect Dis 2009;49:142–147.
- Batchelor BI, Brindle RJ, Gilks GF, Selkon JB. Biochemical mis-identification of Brucella melitensis and subsequent laboratory-acquired infections. J Hosp Infect 1992;22:159–162.
- Klevar S, Høgåsen HR, Davidson RK, Hamnes IS, Treiberg Berndtsson l, Lund A. Cross-border transport of rescue dogs may spread rabies in Europe. Vet Rec 2015;176:672–675.
- Public Health England. Risk Review and Statement on the Risk Brucella Canis Presents to the UK Human Population. Accessed April 2021. Available here.
- Holst BS, Löfqvist K, Ernholm L, Eld K, Cedersmyg M, Hallgren G. The first case of Brucella canis in Sweden: background, case report and recommendations from a northern European perspective. Acta Vet Scand 2021;54:18.
- Dunne J, Sehgal K, McMillan A, Perret L. Canine brucellosis in a dog imported into the UK. Vet Rec 2002;151:247.
- Arenas-Gamboa AM, Rossetti CA, Chaki SP, Garcia-Gonzalez DG, Adams LG, Ficht TA. Human brucellosis and adverse pregnancy outcomes. Curr Trop Med Rep 2016;3: 164–72.
- Santos RL, Souza TD, Mol JPS, Eckstein C, Paíxão TA. Canine brucellosis: An update. Front Vet Sci 2021;8:1–17.
SARS-CoV-2: mutations, variants and traits
- Zhang YZ, Holmes EC. A genomic perspective on the origin and emergence of SARS-CoV-2. Cell 2020;181:223–227.
- Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727–733.
- Drosten C, Günther S, Preiser W, van der Werf S, Brodt HR, Becker S et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967–1976.
- Belshaw R, Gardner A, Rambaut A, Pybus OG. Pacing a small cage: mutation and RNA viruses. Trends Ecol Evol 2008;23:188–193.
- International Committee on Taxonomy of Viruses Executive Committee. The new scope of virus taxonomy: partitioning the virosphere into 15 hierarchical ranks. Nat Microbiol 2020;5:668–674.
- Sanjuán R, Nebot MR, Chirico N, Mansky LM, Belshaw R. Viral mutation rates. J Virol 2010;84:9733–9748.
- Minskaia E, Hertzig T, Gorbalenya AE, Campanacci V, Cambillau C, Canard B et al. Discovery of an RNA virus 3′→5′ exoribonuclease that is critically involved in coronavirus RNA synthesis. Proc Natl Acad Sci USA 2006;103:5108–5113.
- Ogando NS, Zevenhoven-Dobbe JC, van der Meer Y, Bredenbeek PJ, Posthuma CC, Snijder EJ. The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2. J Virol 2020;94:e01246-20.
- Denison MR, Graham RL, Donaldson EF, Eckerle LD, Baric RS. Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity. RNA Biol 2011;8:270–279.
- Dearlove B, Lewitus E, Bai H, Li Y, Reeves DB, Joyce MG et al. A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants. Proc Natl Acad Sci USA 2020;117:23652–23662.
- Yang J, Petitjean SJL, Koehler M, Zhang Q, Dumitru AC, Chen W et al. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat Commun 2020;11:4541.
- Centres for Disease Control and Prevention. SARS-CoV-2 Variant Classifications and Definitions. Accessed May 2021. Available at: www.cdc.gov/coronavirus/2019-ncov/cases-updates/variant-surveillance/variant-info.html
- Plante JA, Liu Y, Liu J, Xia H, Johnson BA, Lokugamage KG et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature 2021;592:116–121.
- Volz E, Mishra S, Chand M, Barrett JC, Johnson R, Geidelberg L et al. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature 2021;593:266–269.
- Kemp SA, Collier DA, Datir RP, Ferreira IATM, Gayed S, Jahun A et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature 2021;592:277–282.
- Ambrosioni J, Blanco JL, Reyes-Urueña JM, Davies MA, Sued O, Marcos MA et al. Overview of SARS-CoV-2 infection in adults living with HIV. Lancet HIV 2021;8:294–305.
- Liu Y, Liu J, Xia H, Zhang X, Fontes-Garfias CR, Swanson KA et al. Neutralizing activity of BNT162b2-elicited serum. N Engl J Med 2021;384:1466–1468.
- Davies NG, Jarvis CI, Edmunds WJ, Jewell NP, Diaz-Ordaz K, Keogh RH. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature 2021;593:270–274.
- Frampton D, Rampling T, Cross A, Bailey H, Heaney J, Byott M et al. Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study. Lancet Infect Dis 2021;doi:10.1016/S1473-3099(21)00170-5 (Epub ahead of print).
- Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday JD et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science 2021;372:eabg3055.
- Public Health England. Investigation of Novel SARS-CoV-2 Variant: Variant of Concern 202012/01. Available at: www.gov.uk/government/publications/phe-investigation-of-novel-sars-cov-2-variant-of-concern-20201201-technical-briefing-3-6-january-2021
- Faria NR, Mellan TA, Whittaker C, Claro IM, Candido DDS, Mishra S et al. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science 2021;372:815–821.
- Buss LF, Prete CA, Abrahim CMM, Mendrone A Jr, Salomon T, de Almeida-Neto C et al. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. Science 2021;371:288–292.
- Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J et al. Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein. Nature 2021;592:438–443.
Vaccine-induced immune thrombocytopenia and thrombosis
- Office for National Statistics. Coronavirus (COVID-19) roundup. Available here.
- Ramasamy MN, Minassian AM, Ewer KJ, Flaxman AL, Folegatti PM, Owens DR et al; Oxford COVID Vaccine Trial Group. Safety vaccine administered in a prime boost regimen in young and old adults (COV002): a single-blind, randomised controlled, phase 2/3 trial. The Lancet 2021;396:1979−1993.
- Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M et al. Pathologic antibodies to platelet factor 4 after ChAdOx1nCov-19 vaccination. N Engl J Med 2021;384:2202−2211.
- Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 2021;384:2092−2101.
- GOV.UK. Coronavirus (COVID-19) in the UK: Deaths in the England. Available at: https://coronavirus.data.gov.uk/details/deaths?areaType=nation%26areaName=England
- Platton S, Bartlett A, MacCallum P, Makris M, McDonald V, Singh D et al. Evaluation of laboratory assays for anti-Platelet Factor 4 antibodies after ChAdOx1 nCOV-19 vaccination. J Thromb Haemost 2021; doi.org/10.1111/jth.15362 (Epub ahead of print).
- Warkentin TE, Makris M, Jay RM, Kelton JG. A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia. Am J Med 2008;121:632−636.
- Warkentin TE, Basciano PA, Knopman J, Bernstein RA. Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder. Blood 2014;123:3651−3654.
- Greinacher A, Selleng K, Warkentin TE. Autoimmune heparin-induced thrombocytopenia. J Thromb Haemost 2017;15:2099−2114.
- Greinacher A, Selleng K, Wesch J, Handtke S, Palankar R, Aurich K et al. Towards Understanding ChAdOx1 nCov-19 Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT). Research Square 2021;doi:10.21203/rs.3.rs-440461/v1 (Preprint).
- von Hundelshausen P, Lorenz R, Siess W, Weber C. Vaccine-induced immune thrombotic thrombocytopenia (VITT): targeting pathomechanisms with Bruton tyrosine kinase inhibitors. Thromb Haemost 2021;doi:10.1055/a-1481-3039 (Epub ahead of print).
- Kowarz E, Krutzke L, Reis J, Bracharz S, Kochanek S, Marschalek R. Vaccine-Induced Covid-19 Mimicry” Syndrome: Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines. Research Square 2021;doi:10.21203/rs.3.rs-558954/v1 (Preprint).
- Pavord S, Lester W, Makris M, Scully M, Hunt B. Guidance from the Expert Haematology Panel (EHP) on Covid-19 Vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT). Published April 2021. Available at: https://b-s-h.org.uk/media/19590/guidance-version-17-on-mngmt-of-vitt-20210420.pdf
RCPath Book Club – sinking our teeth into Gulp
- Bowel Cancer UK. Bowel Cancer. Available at: www.bowelcanceruk.org.uk/about-bowel-cancer/bowel-cancer/
Learning styles of histopathology trainees in the UK
- Fleming ND. Teaching And Learning Styles: VARK Strategies (2nd Edition). Christchurch, New Zealand: The Digital Print and Copy Center, 2005.
- Curry L. Learning preferences in continuing medical education. Canadian Med Assoc J 1981;124:535–536.
- Ahmed A, Wojcik EM, Ananthanarayanan V, Mulder L, Mirza KM. Learning styles in pathology: a comparative analysis and implications for learner-centred education. Acad Pathol 2019;doi:10.1177/2374289519852315.
- Fleming ND, Mills C. Not Another Inventory, Rather A Catalyst For Reflection. 1992. Available at: https://digitalcommons.unl.edu/podimproveacad/246Fleming ND. I’m Different; Not Dumb. Modes Of Presentation (VARK) In The Tertiary Classroom. In: Zelmer A (ed.). Research and Development in Higher Education, Proceedings of the 1995 Annual Conference of the Higher Education and Research Development Society of Australasia (HERDSA). Hammondville, Australia: HERDSA, 1995.
- Sinnerton T, Leonard L, Rogers K. Using learning style preferences to enhance the education and training of allied health professionals. Internet J Allied Health Sci Pract 2014;12:1.
Teaching undergraduate pathology during COVID-19 – sharing experience from our medical school
- Mukhopadhyay S, Booth AL, Calkins SM, Doxtader EE, Fine SW, Gardner JM et al. Leveraging technology for remote learning in the era of COVID-19 and social distancing. Arch Pathol Lab Med 2020;144:1027–1036.
- Samueli B, Sror N, Jotkowitz A, Taragin B. Remote pathology education during the COVID-19 era: Crisis converted to opportunity. Ann Diagn Pathol 2020;49:151612.
- Gosney JR, Hofman P, Troncone G, Lopez-Rios F. Cellular pathology in the COVID-19 era: a European perspective on maintaining quality and safety. J Clin Pathol 2021;74:64–66.
- RCPath. Undergraduate Resources. Accessed April 2021. Available from www.rcpath.org/discover-pathology/undergraduates-and-foundation- doctors/undergraduate-resources.html
- Mayhew E, Davies M, Millmore A, Thompson L, Bizama AP. The impact of audience response platform Mentimeter on the student and staff learning experience. Res Learn Tech 2020;28:2397.
Creation of e-forms in CRRS to facilitate a robust clinical record for clinicians
- General Medical Council. The Shape of Training (2017). Accessed 16 June 2020. Available from: www.gmc-uk.org/-/media/documents/Shape_of_training_FINAL_Report.pdf_53977887.pdf
Paediatric and perinatal pathology
- The Royal College of Pathologists. Sudden Unexpected Death in Infancy and Childhood: Multiagency Guidelines for Care and Investigation. Accessed May 2021. Available at: www.rcpath.org/discover-pathology/news/new-guidelines-for-the-investigation-of-sudden-unexpected-death-in-infancy-launched.html
- Hyde G, Rummery R, Whitby EH, Bloor J, Raghavan A, Cohen MC. Benefits and limitations of the minimally invasive postmortem: a review of an innovative service development. Pediatr Dev Pathol 2020;23:431–437.